
Nanograb
Nanograb is a YC Summer 2023 (S23) company. Based in San Francisco, CA, USA. Team of 5.
About Nanograb
Summary
Nanograb develops AI-generated molecular binders that direct gene therapies and other drugs to specific cell types in the body. The platform identifies optimal binder combinations for a given disease target, replacing the slow, manual process of experimentally screening delivery molecules. Biotech and pharmaceutical teams use it to build cell-type-precise therapies that conventional delivery methods cannot achieve.
From the Y Combinator listing
AI-generated binders for targeted drug delivery
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. Our product allows drugs to be targeted to very specific areas of the body.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 5
- Active
- Early
Founders (3)
- Debesh Mandal
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works